Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Philadelphia Chromosome × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Acute 5 Leukemia, Promyelocytic, Acute 3 Philadelphia Chromosome 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Burkitt Lymphoma 1

Interventions

nilotinib 1 Idarubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01990807 2013-11-21

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

ChineseAMS

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡